A Form 4 filed on September 9, 2026, reports that Steven Barnard, Senior Vice President and Chief Technology Officer of Illumina, Inc. (NASDAQ:ILMN), disposed of 408 shares of common stock on September 5, 2026, under transaction code F.
Daniel Scott Ory, Executive Vice President and Chief Medical Officer of Editas Medicine, Inc., filed a Form 4 on September 9, 2026, disclosing the grant of 950,000 stock options awarded on September 8, 2026.
A Form 4 filed with the SEC on September 9, 2026 discloses that Todd G. Schwartz, Chief Executive Officer, Director, and 10% Owner of OppFi Inc. (NYSE:OPFI), purchased 3,475 shares of Class A Common Stock on September 8, 2026.
A Form 4 filed with the SEC on September 9, 2026, discloses that John W. Smither, a director of NewAmsterdam Pharma Co N.V. (NASDAQ:NAMS), sold 1,600 ordinary shares on September 4, 2026, at a weighted average price of $25.32 per share to cover tax …
Carlos Orestes Vanzo, an officer of Itau Unibanco Holding S.A., filed a Form 4 on September 9, 2026, reporting the sale of 74,643 preferred shares on September 8, 2026.
Chad F. Phipps, Senior Vice President, Chief Legal and Corporate Affairs Officer and Secretary of Zimmer Biomet Holdings, Inc., filed a Form 4 on September 9, 2026, disclosing a sale of common stock that occurred on September 4, 2026.
Andrew Spodek, CEO and Director of Postal Realty Trust, Inc., filed a Form 4 on September 9, 2026, disclosing the acquisition of OP Units on September 4, 2026, through two affiliated entities in connection with property contributions to subsidiaries of the issuer.
Mads Bodenhoff, Senior Vice President and Principal Accounting Officer of Ascendis Pharma A/S (NASDAQ:ASND), filed a Form 4 on September 10, 2026, reporting transactions in ordinary shares and warrants dated September 8, 2026.
A Form 4 filed on September 9, 2026, discloses that Andy Dignan, President of Five9, Inc. (NASDAQ:FIVN), sold a total of 13,320 shares of common stock across four transactions between September 4 and September 8, 2026.
Tiffany N. Meriweather, Chief Administrative and Legal Officer of Five9, Inc., filed a Form 4 on September 9, 2026, disclosing the sale of a combined 18,523 shares of common stock across three transactions between September 4 and September 8, 2026.